42
Participants
Start Date
October 31, 2005
Primary Completion Date
September 30, 2008
Study Completion Date
December 31, 2009
HAART containing nevirapine
Initially NVP 200 mg BID (400 mg per day) was compared to 400 mg BID and 200 mg OD NVP (600 mg per day). 400 mg/day versus 600 mg/day.
The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT), Bangkok
Bamrasnaradura Institute, Nonthaburi
Central Chest Hospital, Nonthaburi
Chiangrai Hospital, Chiang Rai
Mae Chan Hospital, Chiang Rai
Phan Hospital, Chiang Rai
other sponsors:Japanese MOPH
UNKNOWN
Labor and Welfare
UNKNOWN
Thai MOPH
UNKNOWN
Thai GPO
UNKNOWN
Bamrasnaradura Infectious Diseases Institute
OTHER_GOV
Chiang Rai Hospital
OTHER
King Chulalongkorn Memorial Hospital
OTHER
Central General Chest Institute
UNKNOWN
The Research Institute of Tuberculosis (Japan)
UNKNOWN
The HIV Netherlands Australia Thailand Research Collaboration
OTHER